Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Noel James Cusack"'
Autor:
Kimberly R. Byrnes, Richard J. Barohn, Robert C. Griggs, Brian C. Healy, Amanda M. VanDenburgh, Jon Wagg, David J. Loane, Carlos Lopes, Guy J. Buckle, Mark S. Guyer, Noel James Cusack, Amilcar Falcão, Susan A. Gauthier, S. Hua, Michael P. McDermott, Howard L. Weiner, James Stankiewicz, Robyn Guinn, S. Abu-Shakra, M. Vaz-da-Silva, Rebecca A. Betensky, Mark R. Hurtt, Leonel Torrão, Peter Meltzer, Joana Maia, Raquel Costa, Laura Herbelin, José Rocha, Rita Machado, Tatiana Khariton, Mohit Neema, Alan I. Faden, Rui Coelho, Lyndon C. Wright, Zachary D. Guss, Bonnie I. Glanz, Davette Behrens, Ahdeah Pajoohesh-Ganji, Kimberly A. Hart, Jamie Driscoll, Simon Katner, Bruce J. Aungst, Fatta B. Nahab, Ashish Arora, Jason G. Guss, Foster Brown, Antonio Albino-Teixeira, Dominik S. Meier, Samia J. Khoury, M. F. Brin, Ingrid Li, Noel J. Cusack, Charles R.G. Guttmann, Christine Thorne, Patrício Soares-da-Silva, Svetlana Egorova, Mark Hallett, Bruce Solomon, Manasee V. Shah, Lata Venkatarangan, Zsuzsanna Liptak, Candace Rohde, Teresa G. Nunes, F. C. Beddingfield, Barbara E. Herr, Yong Yao, Rohit Bakshi, A. I. Loureiro, Luis Almeida, John Torchia, Linda S. Brady, Bogdan A. Stoica, Loretta Wittevrongel
Publikováno v:
Neurotherapeutics. 5:490-495
Background and Objective An assessment of clinically important change is useful in interpreting clinical trial outcomes. The 4-point Ashworth Scale (AS) is a widely accepted measure of muscle tone, and the 9-point Physician Global Assessment Score (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da15fbe734191d6f9cfe8345a66e54a1
https://doi.org/10.1016/j.nurt.2008.03.002
https://doi.org/10.1016/j.nurt.2008.03.002
Autor:
Noel James Cusack, Davette Behrens, Bruce J. Aungst, Peter Meltzer, Foster Brown, Lata Venkatarangan
Publikováno v:
Neurotherapeutics. 5:494-494
Background and Objective Inhibition of dopamine reuptake via the dopamine transporter (DAT) present on CNS presynaptic dopaminergic neurons is a potential therapy for the treatment of Parkinson's disease (PD). DAT blockers have previously been shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3292b251ee395fa9319ac1ef83d6a144
https://doi.org/10.1016/j.nurt.2008.03.013
https://doi.org/10.1016/j.nurt.2008.03.013